A Phase 2 Efficacy And Safety Study Of SU011248 In Combination With Trastuzumab As Treatment For Metastatic Disease In Patients With Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Sunitinib (Primary) ; Trastuzumab
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 Jul 2011 Last checked against ClinicalTrials.gov record.
- 09 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2010 Planned number of patients changed from 53 to 54 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History